Journal: Frontiers in Microbiology
Article Title: Human beta defensin-3 mediated activation of β-catenin during human respiratory syncytial virus infection: interaction of HBD3 with LDL receptor-related protein 5
doi: 10.3389/fmicb.2023.1186510
Figure Lengend Snippet: Reduced pro-inflammatory response during RSV infection of lung epithelial cells lacking full-length β-catenin protein. (A) CRISPR-Cas9 technology was used to generate stable human lung epithelial A549 cells lacking full-length β-catenin protein. Cell lysates from A549 cells expressing full-length 92 kDa β-catenin protein (FL-catenin-A549 cells) and A549 cells expressing truncated 82 kDa β-catenin protein (Δ-catenin-A549 cells) were subjected to western blotting with β-catenin antibody. (B) TOP-Flash luciferase assay of A549 cells expressing either FL-catenin or Δ-catenin were co-transfected with firefly-luciferase-TOP-Flash and renilla-luciferase plasmids. Co-transfected cells were treated with Lithium Chloride (LiCl; 25 mM) for 24 h. A dual luciferase reagent was utilized to determine firefly and renilla luciferase activity. The relative TOP-Flash luciferase activity was calculated based on the mean value of firefly/renilla luciferase activity. The value is represented as a fold change in TOP-Flash activity in LiCl-treated cells compared to vehicle (water) treated cells. (C) A549 cells expressing either FL-catenin or Δ-catenin were infected with RSV (MOI = 3). Medium supernatant collected from these cells was analyzed for IL-8 production by ELISA. Luciferase assay represents mean ± SEM from two independent experiments performed in triplicates [* p ≤ 0.05 ( n = 16; technical replicates)]. ELISA data are shown as Mean ± SEM [* p ≤ 0.05 ( n = 24; technical replicates; three independent experiments)].
Article Snippet: Cells (A549, FL-catenin, and Δ-catenin cells) were co-transfected with M50 Super 8× TOP-Flash firefly luciferase reporter plasmid (Addgene) and a plasmid encoding Renilla luciferase for 16 h. Transfected cells were either infected with RSV or treated with purified HBD3 protein.
Techniques: Infection, CRISPR, Expressing, Western Blot, Luciferase, Transfection, Activity Assay, Enzyme-linked Immunosorbent Assay